Development of small molecules designed to modulate protein-protein interactions.

Journal of Computer-aided Molecular Design
Ye CheGarland R Marshall

Abstract

Protein-protein interactions are ubiquitous, essential to almost all known biological processes, and offer attractive opportunities for therapeutic intervention. Developing small molecules that modulate protein-protein interactions is challenging, owing to the large size of protein-complex interface, the lack of well-defined binding pockets, etc. We describe a general approach based on the "privileged-structure hypothesis" [Che, Ph.D. Thesis, Washington University, 2003] - that any organic templates capable of mimicking surfaces of protein-recognition motifs are potential privileged scaffolds as protein-complex antagonists--to address the challenges inherent in the discovery of small-molecule inhibitors of protein-protein interactions.

References

Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R J SimonC K Marlowe
Jul 1, 1990·Journal of Medicinal Chemistry·P WardJ R Brown
Mar 1, 1991·International Journal of Peptide and Protein Research·G D SmithG R Marshall
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G R MarshallM T Leplawy
Jan 1, 1985·Advances in Protein Chemistry·G D RoseJ A Smith
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S Marqusee, R L Baldwin
Dec 1, 1988·International Journal of Peptide and Protein Research·A M FelixV Toome
Jan 1, 1984·Annual Review of Biochemistry·C O Pabo, R T Sauer
Jan 1, 1984·CRC Critical Reviews in Biochemistry·B V Prasad, P Balaram
Jan 20, 1995·Science·T Clackson, J A Wells
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·H I Chen, M Sudol
Oct 1, 1994·International Journal of Peptide and Protein Research·S ZerkoutM Marraud
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·T S JardetzkyD C Wiley
Jul 1, 1996·Bioorganic & Medicinal Chemistry·A B SmithR Hirschmann
Mar 21, 1997·Journal of Molecular Biology·J Fernández-RecioJ Sancho
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·P ArmandE K Bradley
Jul 7, 1998·Journal of Molecular Biology·A A Bogan, K S Thorn
Feb 2, 1999·Journal of Molecular Biology·L Lo ConteJ Janin
Mar 26, 1999·Bioorganic & Medicinal Chemistry Letters·E K DziadulewiczP J Garratt
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·I D KuntzP A Kollman
Nov 5, 1999·Journal of Molecular Biology·D E Draper
Feb 26, 2000·Science·W L DeLanoJ A Wells

❮ Previous
Next ❯

Citations

Aug 27, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Emilio Margolles-ClarkPeter Buchwald
Dec 25, 2010·Journal of the American Chemical Society·Eunhwa KoKevin Burgess
May 26, 2011·Journal of the American Chemical Society·Landon R WhitbyDale L Boger
Jun 27, 2009·Circulation Research·Vandana VermaMario Delmar
Jan 19, 2012·Journal of Computer-aided Molecular Design·G SeddonG Vriend
Dec 14, 2007·Expert Opinion on Therapeutic Targets·Ye Che, Garland R Marshall
May 16, 2008·Expert Opinion on Therapeutic Targets·Alexander B Sigalov
Jan 24, 2014·Drug Discovery Today. Technologies·Darren Fayne
Apr 23, 2013·Plant Science : an International Journal of Experimental Plant Biology·Anna WawrzyńskaAgnieszka Sirko
Oct 13, 2012·Medicinal Research Reviews·Weisi Wang, Yongzhou Hu
Jul 22, 2009·Journal of Molecular Recognition : JMR·Peter BuchwaldCamillo Ricordi
Jul 1, 2016·Journal of Medicinal Chemistry·Ranganath GopalakrishnanEric Valeur
Dec 29, 2016·Journal of the American Chemical Society·Anthony J MetranoScott J Miller
Mar 27, 2007·Chemical Biology & Drug Design·Ye CheGarland R Marshall
Sep 18, 2007·Biopolymers·Garland R MarshallDaniel J Kuster
Feb 20, 2009·Chemical Communications : Chem Comm·Eric Meggers
Nov 1, 2009·Nature Chemistry·Dan L Sackett, David Sept
Mar 9, 2019·Organic & Biomolecular Chemistry·Jaru TaechalertpaisarnKevin Burgess
Apr 20, 2007·Biopolymers·Ye CheGarland R Marshall
Feb 13, 2020·Biological Chemistry·Ave KuuskChristian Ottmann
Apr 13, 2011·Chemical Society Reviews·Eunhwa KoKevin Burgess
Jun 1, 2011·Chemistry, an Asian Journal·Susana GordoErnest Giralt
Jun 23, 2015·Chembiochem : a European Journal of Chemical Biology·Sara FahsTimothy J Snape
Sep 7, 2017·Drug Development Research·Garland R Marshall, Flavio Ballante
Sep 2, 2009·Organic Letters·Srinivasa MarimgantiJung-Mo Ahn
May 15, 2009·The Journal of Organic Chemistry·Santos FusteroJosé Luis Aceña
Sep 17, 2013·Journal of Chemical Information and Modeling·Serge PeratoSylvain Rault
Sep 19, 2017·Journal of Chemical Information and Modeling·Nicolas BoscOlivier Sperandio
Dec 27, 2011·Journal of Chemical Information and Modeling·Jana Sopkova-de Oliveira SantosSylvain Rault
Oct 13, 2017·Journal of Medicinal Chemistry·Jinshui ChenPeter Buchwald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Current Topics in Medicinal Chemistry
Stefan J HershbergerJean Chmielewski
Chemical Society Reviews
Eunhwa KoKevin Burgess
Journal of the Royal Society, Interface
Steven Fletcher, Andrew D Hamilton
Current Opinion in Chemical Biology
Christopher G Cummings, Andrew D Hamilton
© 2022 Meta ULC. All rights reserved